Suvanza Pharma, LLC
SUVZ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.01M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.01 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $- |
| Beta | 0.6 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Suvanza Pharma, LLC
0CEO: Nardo Zaias
Suvanza Pharma, LLC is an emerging biotechnology enterprise dedicated to developing RapiDerm, an innovative drug delivery system applied to the skin, specifically targeting dermatological disorders. The company, which began operations in...